Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Compliance and regulatory

MHRA Launches AdvanceGxP Service for Medicines Manufacturing

The MHRA has launched AdvanceGxP, a new regulatory support service designed to guide innovative medicines manufacturing technologies through compliance requirements.

Published 18 Nov 2026· 2 minute read
MHRA headquarters sign in London.
Photo: Environmental Protection Agency. Office of the Administrator. Office of Public Affairs. Office of Multimedia. (10/15/201 / Wikimedia Commons, Public domain (cropped). Source

Lede

The UK Medicines and Healthcare products Regulatory Agency (MHRA), in collaboration with the Office for Life Sciences (OLS), has launched AdvanceGxP, a new regulatory support service aimed at organizations developing novel medicines manufacturing technologies. This service provides early, practical guidance on Good Practice (GxP) requirements to reduce development uncertainty and accelerate the path to regulatory compliance for innovative manufacturing methods.

What happened

The MHRA announced the launch of AdvanceGxP in November 2026. The initiative targets companies and research institutions working on advanced, often disruptive, manufacturing technologies—such as point-of-care production, automated systems, and novel biological processes—that do not fit neatly into existing regulatory frameworks.

Key details

AdvanceGxP offers:

  • Early regulatory engagement to identify potential compliance gaps in novel manufacturing workflows.
  • Practical guidance on adapting Good Practice (GxP) standards to cutting-edge manufacturing processes.
  • A streamlined path for innovators to discuss regulatory expectations before committing to major facility investments.

The MHRA emphasizes that this service is intended to support the entire spectrum of life sciences innovation, ensuring that high safety and quality standards are maintained while removing unnecessary regulatory barriers.

Background and context

As medicines manufacturing becomes increasingly complex, regulatory frameworks—historically built for conventional, large-batch production—have struggled to keep pace with agile, small-batch, and highly technical manufacturing innovations. The launch of AdvanceGxP is a targeted effort to address these challenges, ensuring that the UK remains a competitive environment for biotech and life sciences research.

Reaction

Industry stakeholders have welcomed the initiative, highlighting the importance of regulatory clarity for accelerating drug development. Compliance experts note that for research institutions and spin-outs, early MHRA involvement is essential to avoiding costly redesigns at later stages of development.

What it means for researchers, universities and research offices

For universities and research institutions with active spin-outs or pilot manufacturing capabilities, AdvanceGxP offers a critical avenue for regulatory derisking. Research offices should monitor MHRA announcements for information on how to engage with this service for their early-stage manufacturing projects. Proactive engagement can ensure that innovative manufacturing solutions are built with GxP compliance at their core.

What happens next

The service is now active for early adopters. The MHRA is expected to publish further details on engagement procedures and specific eligibility criteria for manufacturing innovators. Research institutions should review their current manufacturing technology pipelines to determine if they could benefit from early consultation under AdvanceGxP.

Sources

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →